126 related articles for article (PubMed ID: 8741997)
1. No-carrier-added (4-fluoro-3-[131I]iodobenzyl)guanidine and (3-[211At]astato-4-fluorobenzyl)guanidine.
Vaidyanathan G; Affleck DJ; Zalutsky MR
Bioconjug Chem; 1996; 7(1):102-7. PubMed ID: 8741997
[TBL] [Abstract][Full Text] [Related]
2. 3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.
Vaidyanathan G; Zhao XG; Larsen RH; Zalutsky MR
Br J Cancer; 1997; 76(2):226-33. PubMed ID: 9231923
[TBL] [Abstract][Full Text] [Related]
3. 1-(m-[211At]astatobenzyl)guanidine: synthesis via astato demetalation and preliminary in vitro and in vivo evaluation.
Vaidyanathan G; Zalutsky MR
Bioconjug Chem; 1992; 3(6):499-503. PubMed ID: 1463779
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
[TBL] [Abstract][Full Text] [Related]
5. No-carrier-added synthesis of meta-[131I]iodobenzylguanidine.
Vaidyanathan G; Zalutsky MR
Appl Radiat Isot; 1993 Mar; 44(3):621-8. PubMed ID: 8472027
[TBL] [Abstract][Full Text] [Related]
6. (4-[18F]fluoro-3-iodobenzyl)guanidine, a potential MIBG analogue for positron emission tomography.
Vaidyanathan G; Affleck DJ; Zalutsky MR
J Med Chem; 1994 Oct; 37(21):3655-62. PubMed ID: 7932592
[TBL] [Abstract][Full Text] [Related]
7. No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog.
Vaidyanathan G; Zhao XG; Strickland DK; Zalutsky MR
J Nucl Med; 1997 Feb; 38(2):330-4. PubMed ID: 9025764
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of alpha-particle-emitting m-[211At]astatobenzylguanidine on human neuroblastoma cells.
Strickland DK; Vaidyanathan G; Zalutsky MR
Cancer Res; 1994 Oct; 54(20):5414-9. PubMed ID: 7923174
[TBL] [Abstract][Full Text] [Related]
9. Carrier-free 131I-meta-iodobenzylguanidine: comparison of production from meta-diazobenzylguanidine and from meta-trimethylsilylbenzylguanidine.
Mairs RJ; Gaze MN; Watson DG; Skellern GG; Constable P; McKellar K; Owens J; Vaidyanathan G; Zalutsky MR
Nucl Med Commun; 1994 Apr; 15(4):268-74. PubMed ID: 8072739
[TBL] [Abstract][Full Text] [Related]
10. Radiolabeled (4-Fluoro-3-Iodobenzyl)Guanidine Improves Imaging and Targeted Radionuclide Therapy of Norepinephrine Transporter-Expressing Tumors.
Yamaguchi A; Hanaoka H; Higuchi T; Tsushima Y
J Nucl Med; 2018 May; 59(5):815-821. PubMed ID: 29217738
[No Abstract] [Full Text] [Related]
11. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
[TBL] [Abstract][Full Text] [Related]
12. Method for radioiodination of proteins using N-succinimidyl 3-hydroxy-4-iodobenzoate.
Vaidyanathan G; Affleck DJ; Zalutsky MR
Bioconjug Chem; 1997; 8(5):724-9. PubMed ID: 9327137
[TBL] [Abstract][Full Text] [Related]
13. 211At- and 131I-labeled bisphosphonates with high in vivo stability and bone accumulation.
Larsen RH; Murud KM; Akabani G; Hoff P; Bruland OS; Zalutsky MR
J Nucl Med; 1999 Jul; 40(7):1197-203. PubMed ID: 10405142
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
Weber W; Weber J; Senekowitsch-Schmidtke R
Cancer Res; 1996 Dec; 56(23):5428-34. PubMed ID: 8968097
[TBL] [Abstract][Full Text] [Related]
15. Preparation of 5-[131I]iodo- and 5-[211At]astato-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) uracil by a halodestannylation reaction.
Vaidyanathan G; Zalutsky MR
Nucl Med Biol; 1998 Jul; 25(5):487-96. PubMed ID: 9720667
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of structurally identical fluorine-18 and iodine isotope labeling compounds for comparative imaging.
Li Z; Ding YS; Gifford A; Fowler JS; Gatley JS
Bioconjug Chem; 2003; 14(2):287-94. PubMed ID: 12643738
[TBL] [Abstract][Full Text] [Related]
17. Radiochemical purity, at expiry, and radiochemical stability of iodine-131 labelled meta-iodobenzylguanidine concentrates for intravenous infusion.
Wafelman AR; Hoefnagel CA; Maes RA; Beijnen JH
Nuklearmedizin; 1996 Aug; 35(4):122-5. PubMed ID: 8784866
[TBL] [Abstract][Full Text] [Related]
18. N-succinimidyl 3-[(131)I]iodo-4-phosphonomethylbenzoate ([(131)I]SIPMB), a negatively charged substituent-bearing acylation agent for the radioiodination of peptides and mAbs.
Shankar S; Vaidyanathan G; Affleck D; Welsh PC; Zalutsky MR
Bioconjug Chem; 2003; 14(2):331-41. PubMed ID: 12643743
[TBL] [Abstract][Full Text] [Related]
19. A convenient and reproducible method for the synthesis of astatinated 4-[
Watanabe S; Azim MA; Nishinaka I; Sasaki I; Ohshima Y; Yamada K; Ishioka NS
Org Biomol Chem; 2018 Dec; 17(1):165-171. PubMed ID: 30534678
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of carrier-free 131I-meta-iodobenzyl-guanidine by novel routes to enhance therapeutic efficiency in neuroblastoma.
Gaze MN; Mairs RJ; Vaidyanathan G; Zalutsky MR
Prog Clin Biol Res; 1994; 385():347-53. PubMed ID: 7972229
[No Abstract] [Full Text] [Related]
[Next] [New Search]
